Tarhini, A. A., Tan, A. C., Xie, M., El Naqa, I., Saghand, P. G., Dai, D., … Weiner, G. J. (2022). Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

Tarhini, Ahmad A., Aik Choon Tan, Mengyu Xie, Issam El Naqa, Payman Ghasemi Saghand, Donghai Dai, James Lin Chen, et al. “Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

Tarhini AA, Tan AC, Xie M, El Naqa I, Saghand PG, Dai D, et al. Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

Tarhini, Ahmad A., et al. “Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

Tarhini AA, Tan AC, Xie M, El Naqa I, Saghand PG, Dai D, Chen JL, Ratan A, McCarter M, Carpten JD, Colman H, Ikeguchi A, Tripathi A, Puzanov I, Arnold SM, Churchman ML, Hwu P, Conejo-Garcia J, Dalton WS, Weiner GJ. Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data. JOURNAL OF CLINICAL ONCOLOGY. 2022.